Clinical trial
Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free…
NCT00157053 · Baxalta now part of Shire, Industry · Completed
Key facts
| NCT number | NCT00157053 |
|---|---|
| Title | Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901 |
| Official title | Evaluation of Pharmacokinetics, Safety, Efficacy and Immunogenicity of rAHF-PFM in Previously Treated Hemophilia A Patients - A Continuation Study |
| Lead sponsor | Baxalta now part of Shire, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hemophilia A |
| Intervention type | Drug |
| Interventions | Antihemophilic factor, recombinant, manufactured protein-free |
| Enrollment | 82 |
| Start date | Nov 22, 2001 |
| Primary completion | Aug 3, 2004 |
| Completion | Aug 3, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Aug 24, 2021 |
| Countries | Austria, Belgium, Canada, France, Germany, Italy, Sweden, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: